ANN ARBOR, Mich., Oct. 24, 2025 — ENDRA Life Sciences has taken its first step into digital assets, establishing a digital-asset treasury (DAT) and deploying $3 million to acquire 78,863 HYPE tokens, according to a company press release.
The move follows the completion of a $4.9 million private placement (PIPE) led by institutional and crypto investors. The investment marks ENDRA’s strategic entry into decentralized finance (DeFi) as it seeks to integrate yield-generating digital assets into its corporate treasury.
At the time of purchase, HYPE — the native token of the Hyperliquid ecosystem — traded around $39.30, rising nearly 10% amid growing institutional activity.
“This marks a foundational step in our long-term digital asset treasury strategy,” said Alexander Tokman, CEO of ENDRA Life Sciences. “By aligning with Arca Investment Management’s highest-conviction DeFi holdings, we’re not just preserving capital — we’re putting it to work in some of the most innovative yield ecosystems in the world.”
The company stated that its HYPE position will form the cornerstone of a broader DAT framework designed to enhance returns through:
- Staking within the Hyperliquid protocol
- Options overlays and structured yield strategies
- Participation in DeFi liquidity programs
ENDRA added that its goal is to grow its “tokens-per-share” ratio — a metric reflecting shareholder value in terms of direct crypto asset exposure.
The move comes amid heightened institutional attention toward HYPE. Earlier this week, Hyperliquid Strategies, a newly formed digital-asset treasury firm resulting from a merger involving Sonnet BioTherapeutics, filed with the SEC to raise $1 billion, with a portion earmarked for HYPE token acquisitions.
With this investment, ENDRA becomes one of the first publicly listed U.S. companies to formally integrate DeFi assets into its balance sheet as part of a structured treasury management strategy.
 and deploying $3 million to...){kind=link}